President-elect Biden will soon announce his pick for the next Attorney General, and rumors are already swirling over possible candidates. For cannabis consumers and patients, as well as reformers, regulators, and members of the industry, few roles in the federal government will be more important than that of the United States Attorney General. 

MPP is excited to be moving into 2018 at a time when marijuana policy reform has unprecedented momentum. While there are sure to be challenges ahead, MPP is confident that we will make great strides this year. You can find the strategic plan here. In a great sign of things to come, one of our goals is already on the verge of success. On Thursday, the Vermont legislature passed a bill that would make possession and limited home cultivation legal in the Green Mountain State! The bill is expected to…

The Drug Enforcement Administration (DEA) has decided that marijuana will remain classified as a Schedule I substance under the Controlled Substances Act. The decision to keep marijuana in the category reserved for drugs with no accepted medical uses and a high potential for abuse was, according to the DEA, based on consultation with the Department of Health and Human Services. According to DEA administrator Chuck Rosenberg, “If the scientific understanding about marijuana changes — and it could…

In response to the recent decision by the DEA not to move marijuana out of Schedule I of the Controlled Substances Act, MPP's Rob Kampia offered the following analysis of the situation, and what the best course of action would be: In the wake of the DEA’s decision against rescheduling marijuana, the super-majority of the American people who support legalizing medical marijuana might properly wonder, “How bad is this news?” As the leader of the largest marijuana-policy-reform organization in the…